Cilt 47, Sayı 1, Sayfalar 1 - 4 2017-07-31

Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease

Nihan Çarçak Yılmaz [1] , Merve Altuntaş [2] , Y. Kübra Akyel Akyel [3] , B. Sönmez Uydeş Doğan [4]

66 44

           Alzheimer Disease (AD) characterized by the progressive cognitive and functional impairment, is the most common form of dementia affecting people worldwide. In this study, we aimed to investigate the profile of patients with AD, the perception of caregivers about the disease and the role of pharmacist in the pharmacotherapy of AD by implementing a questionnaire for the caregivers of 44 patients with AD.  70% of the evaluated patients with AD is female gender and in 52% of the cases, hypertension co-exists with AD. The combination of memantine/donepezil (34%) was found the most commonly used pharmacological treatment in the patients which was associated with various adverse effects such as headache, insomnia, fatigue, and hallucinations.

An average of 70% of the caregivers benefit from the pharmacists in regard to the use of drugs (94%), information about disease and side effects (48%) and drug-drug interactions (42%). Additionally, the 77% of caregivers who benefit from pharmacists were well satisfied with this support. In conclusion, patients with AD and their caregivers need a professional assistance regarding the use of drugs and modalities how to fight with the disease. Pharmacists play a significant role in both following the pharmacotheraphy of AD patients and the education of caregivers. Thus, pharmacist’s role in the management of rational pharmacotherapy should be strengthened by providing a continued educational support. 

Alzheimer Disease,pharmacist,pharmacotherapy applicatios,caregivers
  • Atri A, Shaughnessy LW, Locascio JJ, Growdon JH (2008) Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 22(3):209-221.
  • Cummings JL, Cole G (2002) Alzheimer disease. JAMA. 287:2335–2338.
  • Dantoine T, Auriacombe S, Sarazin M, Becker H, Pere JJ, Bourdeix I (2006) Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment. Int J Clin Pract. 60(1):110-118.
  • Feinberg MV, Michocki RJ (1998) Clinical and regulatory concerns in Alzheimer’s disease management: role of pharmacist. Am J Health Syst Pharm. 55(Suppl 2):26-31.
  • Gaugler JE1, Pot AM, Zarit SH (2007) Long-term adaptation to institutionalization in dementia caregivers. Gerontologist. 47(6):730-740.
  • Graham WV, Bonito-Oliva A, Sakmar TP (2017) Update on Alzheimer’s Disease Theraphy and Prevention Strategies. Annu.Rev.Med. 68:413-430.
  • Gurvit H, Emre M, Tinaz S, Bilgic B, Hanagasi H, Sahin H, Gurol E, Kvaloy JT, Harmanci H (2008) The prevalence of dementia in an urban Turkish population. Am J Alzheimers Dis Other Demen. 23(1):67-76. doi: 10.1177/1533317507310570.
  • Haley WE (1997) The family caregiver’s role in Alzheimer’s Disease. Neurology 48(Suppl 6):25-29.
  • Novais T, Moutet C, Deplhin-Combe F, Dauphinot V, Colin C, Krolak-Salmon P, Mouchhoux C, the PHARMAID study group (2017) PHARMAID study protocol:Randomized controlled trial to assess the impact of integrated pharmaceutical care at psychosocial intervention on caregiver’s burden in Alzheimer’s Disease or related diseases. Contemp Clin Trials 53:137-142.
  • Mucke L (2009) Alzheimer’s Disease. Neuroscience 461:895-897.
  • Papastavrou E, Kolekerinou A, Papacostas S, Tsangari H, Sourtzi P (2007) Caring for a relative with dementia: Family caregiver burden. J Adv Nurs 58:446-457.
  • Patwardhan A, Duncan I, Murphy P, Pegus C (2012) The value of pharmacists in health care. Popul Health Manag. 15(3):157-62. doi: 10.1089/pop.2011.0030.
  • Rickles NM, Skelton JB, Davis J, Hopson J (2014) Cognitive memory screening and referral program in community pharmacies in the United States. Int J Clin Pharm 36:360-367.
  • Schubert CC, Boustani M, Callahan CM, et al (2006) Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc. 54(1):104–119.
  • Sevilla C, Jimenez Caballero PE, Alfonso V, Gonzalez-Adalid M (2009) Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? Dement Geriatr Cogn Disord. 28:196–205.
  • Skelton JB (2008) White paper on expanding the role of pharmacists in caring for individuals with Alzheimer's disease: APhA Foundation Coordinating Council to Improve Collaboration in Supporting Patients with Alzheimer's Disease. J Am Pharm Assoc. 48(6):715-21. doi: 10.1331/JAPhA.2008.08144.
  • Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 291(3):317-324.
  • Tett SE, Higgins GM, Armour CL (1993) Impact of pharmacist interventions on medication management in elderly: a review of literature. Ann Pharmacother. 27:80-86
  • Turkish Ministy of Health, Statistics, Analysis And Reporting Department Report Bulletin. World Alzheimer's Awareness Day 21 September 2015 (2015) Issue 11. http://www.tkhk.gov.tr/Dosyalar/98f8dcd91e514090804776447e9a3d3c.pdf
  • Verez Cotelo N, Andres Rodriguez NF, Fornos Perez JA, Andres Iglesias JC, Rios Lago M (2015) Burden and associated pathologies in family caregivers of Alzheimer’s disease in patients in Spain. Pharmacy Practice 13(2):521-527.
  • Watanabe N, Yamamura K, Suzuki Y, Umegaki H, Shigeno K, Matsushita R, Sai Y, Miyamoto K, Yamada K (2012) Pharmacist-based Donepezil Outpatient Consultation service to improve medication persistence. Patient Prefer Adherence 6:605-611.
  • Wiens C (2003) The Challenges of Medication Management in Patients with Alzheimer’s Disease. The Canadian Alzheimer Disease Review 16-19
  • Yıkılkan H, Aypak C, Görpelioğlu S (2014) Depression, anxiety and quality of life in caregivers of long-term home care patients. Arc of Psychiatr Nurs 28:193-196.
  • Zerafa N, Scerri C (2016) Knowledge and pharmacological management of Alzheimer’s disease by managing community pharmacist: a nationwide study. Int J Clin Pharm 38:1416-1424.
  • Zheng WH, Bastianetto S, Mennicken F, et al. (2002)Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience. 115:201–211.
Konular Farmakoloji ve Eczacılık
Dergi Bölümü Original Article
Yazarlar

Yazar: Nihan Çarçak Yılmaz
E-posta: nihan.carcak@istanbul.edu.tr
Kurum: Istanbul University Faculty of Pharmacy Department of Pharmacology
Ülke: Turkey


Yazar: Merve Altuntaş
E-posta: mervi_als@hotmail.com
Kurum: Istanbul University Faculty of Pharmacy
Ülke: Turkey


Yazar: Y. Kübra Akyel Akyel
E-posta: yaseminkubraakyel@gmail.com
Kurum: Istanbul University Faculty of Pharmacy Department of Pharmacology
Ülke: Turkey


Yazar: B. Sönmez Uydeş Doğan
E-posta: sonmezuydesdogan@gmail.com
Kurum: Istanbul University Faculty of Pharmacy Department of Pharmacology
Ülke: Turkey


Bibtex @araştırma makalesi { iujp296281, journal = {Istanbul Journal of Pharmacy}, issn = {2548-0731}, address = {İstanbul Üniversitesi}, year = {2017}, volume = {47}, pages = {1 - 4}, doi = {10.5152/IstanbulJPharm.2017.001}, title = {Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease}, language = {en}, key = {cite}, author = {Akyel, Y. Kübra Akyel and Çarçak Yılmaz, Nihan and Altuntaş, Merve and Uydeş Doğan, B. Sönmez} }
APA Çarçak Yılmaz, N , Altuntaş, M , Akyel, Y , Uydeş Doğan, B . (2017). Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease. Istanbul Journal of Pharmacy, 47 (1), 1-4. DOI: 10.5152/IstanbulJPharm.2017.001
MLA Çarçak Yılmaz, N , Altuntaş, M , Akyel, Y , Uydeş Doğan, B . "Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease". Istanbul Journal of Pharmacy 47 (2017): 1-4 <http://dergipark.gov.tr/iujp/issue/30716/296281>
Chicago Çarçak Yılmaz, N , Altuntaş, M , Akyel, Y , Uydeş Doğan, B . "Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease". Istanbul Journal of Pharmacy 47 (2017): 1-4
RIS TY - JOUR T1 - Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease AU - Nihan Çarçak Yılmaz , Merve Altuntaş , Y. Kübra Akyel Akyel , B. Sönmez Uydeş Doğan Y1 - 2017 PY - 2017 N1 - doi: 10.5152/IstanbulJPharm.2017.001 DO - 10.5152/IstanbulJPharm.2017.001 T2 - Istanbul Journal of Pharmacy JF - Journal JO - JOR SP - 1 EP - 4 VL - 47 IS - 1 SN - 2548-0731- M3 - doi: 10.5152/IstanbulJPharm.2017.001 UR - http://dx.doi.org/10.5152/IstanbulJPharm.2017.001 Y2 - 2017 ER -
EndNote %0 Istanbul Journal of Pharmacy Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease %A Nihan Çarçak Yılmaz , Merve Altuntaş , Y. Kübra Akyel Akyel , B. Sönmez Uydeş Doğan %T Pharmacist’s Role in Pharmacotherapeutic Management of Alzheimer’s Disease %D 2017 %J Istanbul Journal of Pharmacy %P 2548-0731- %V 47 %N 1 %R doi: 10.5152/IstanbulJPharm.2017.001 %U 10.5152/IstanbulJPharm.2017.001